These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36438645)

  • 1. HIV-1 Genotypic Resistance Testing Using Sanger and Next-Generation Sequencing in Adults with Low-Level Viremia in China.
    Li Q; Yu F; Song C; Zhao H; Xiao Q; Lao X; Yang S; Tang Y; Zhang F
    Infect Drug Resist; 2022; 15():6711-6722. PubMed ID: 36438645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Concentration Method for HIV Drug Resistance Testing in Low-Level Viremia Samples.
    Li Q; Yu F; Song C; Zhao H; Yan L; Xiao Q; Lao X; Yang S; Tang Y; Xiao J; Zhang F
    Biomed Res Int; 2022; 2022():2100254. PubMed ID: 36467892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an
    Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads.
    Bareng OT; Choga WT; Maphorisa ST; Seselamarumo S; Seatla KK; Mokgethi PT; Maruapula D; Mogwele ML; Ditshwanelo D; Moraka NO; Gobe I; Motswaledi MS; Makhema JM; Musonda R; Shapiro R; Essex M; Novitsky V; Moyo S; Gaseitsiwe S
    Infect Drug Resist; 2022; 15():7565-7576. PubMed ID: 36582452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
    Balakrishna S; Loosli T; Zaheri M; Frischknecht P; Huber M; Kusejko K; Yerly S; Leuzinger K; Perreau M; Ramette A; Wymant C; Fraser C; Kellam P; Gall A; Hirsch HH; Stoeckle M; Rauch A; Cavassini M; Bernasconi E; Notter J; Calmy A; Günthard HF; Metzner KJ; Kouyos RD
    J Antimicrob Chemother; 2023 Mar; 78(3):656-664. PubMed ID: 36738248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China.
    Chen X; Zou X; He J; Zheng J; Chiarella J; Kozal MJ
    PLoS One; 2016; 11(2):e0149215. PubMed ID: 26895182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First evaluation of the Next-Generation Sequencing platform for the detection of HIV-1 drug resistance mutations in Belgium.
    Dessilly G; Goeminne L; Vandenbroucke AT; Dufrasne FE; Martin A; Kabamba-Mukadi B
    PLoS One; 2018; 13(12):e0209561. PubMed ID: 30596682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
    Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
    Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
    May S; Adamska E; Tang J
    J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic landscape for majority and minority HIV-1 drug resistance mutations in antiretroviral therapy naive patients in Accra, Ghana.
    Appiah P; Gbassana G; Adusei-Poku M; Obeng BM; Duedu KO; Sagoe KWC
    Heliyon; 2024 Jun; 10(12):e33180. PubMed ID: 39022058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    Bangalee A; Hans L; Steegen K
    J Antimicrob Chemother; 2021 Sep; 76(10):2659-2665. PubMed ID: 34278422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    Kao SW; Liu ZH; Wu TS; Ku SW; Tsai CL; Shie SS; Huang PY; Wu YM; Hsiao YH; Chen NY
    J Antimicrob Chemother; 2021 Feb; 76(3):722-728. PubMed ID: 33331635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.
    Lan Y; Ling X; Deng X; Lin Y; Li J; Li L; He R; Cai W; Li F; Li L; Hu F
    Infect Drug Resist; 2023; 16():4953-4964. PubMed ID: 37546367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
    Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
    BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
    Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
    J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
    Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
    J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
    Gonzalez-Serna A; Min JE; Woods C; Chan D; Lima VD; Montaner JS; Harrigan PR; Swenson LC
    Clin Infect Dis; 2014 Apr; 58(8):1165-73. PubMed ID: 24429436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
    Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
    Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
    Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shall I trust the report? Variable performance of Sanger sequencing revealed by deep sequencing on HIV drug resistance mutation detection.
    Chen NY; Kao SW; Liu ZH; Wu TS; Tsai CL; Lin HH; Wong WW; Chang YY; Chen SS; Ku SW
    Int J Infect Dis; 2020 Apr; 93():182-191. PubMed ID: 32061862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.